Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

News and notifications

New executive order raises fees in the area of the Danish Medicines Agency

03 May 2022

Higher fees become payable for medicinal products and pharmaceutical companies as a result of a new executive order entering into force on 1 May 2022. The last time the fees were adjusted was in 2017.

Danish Medicines Agency presents new strategy

05 April 2022

2021 deadline for submitting applications concerning marketing authorisations and clinical trials

08 November 2021

Danish Medicines Agency investigates a case of inflammatory condition reported after COVID-19 vaccination

26 August 2021